Judy Walker

R&D

September was Alzheimer’s Month, and with that in mind pharmaphorum spoke to leaders at two biotechs about latest developments in the field.

News

AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.